Tag: publication

Issued on behalf of Greenland Mines LtdWith its latest investment, a Nasdaq-listed developer is betting that owning the processing and conversion layer — not...

Per Narvinger, currently Executive Vice President and Head of Business Area Networks, to become President and Chief Executive Officer of EricssonBörje Ekholm to step...

Craveable snack brand, Jackson's, has been recognized for the third consecutive year as consumers continue seeking bold flavor and feel-good ingredients MUSKEGO, Wis., June 16,...

Issued on behalf of MindWalk Holdings Corp.Everyone is racing to point powerful AI models at drug discovery. A growing camp argues the real prize...

Per Narvinger, currently Executive Vice President and Head of Business Area Networks, to become President and Chief Executive Officer of EricssonBörje Ekholm to step...

REYKJAVIK, Iceland , June 16, 2026 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO; ALVO-SDB) (“Alvotech” or the “Company”), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced the pricing of its previously announced underwritten public offering (the “Offering”) of 22,666,667 of its ordinary shares at an offering price of $3.75 per share. All ordinary shares to be sold in the Offering will be offered by Alvotech. The Offering is expected to close on or about June 17, 2026, subject to satisfaction of customary closing conditions. The Company has also granted the underwriters a 30-day option to purchase up to an additional 3,400,000 ordinary shares at the public offering price, less underwriting discounts and commissions. Before deducting the underwriting discounts and commissions and offering expenses, the Company expects to receive total gross proceeds of approximately $85 million from the Offering, or approximately $98 million if the underwriters exercise in full their option to purchase additional shares.

Transparency notification Stichting Pensioenfonds ABP

The Boston Business Journal has named Interra Health to its 2026 Best Places to Work list.

Greensboro managed IT and security provider passes the full 110-control CMMC Level 2 assessment with zero findings, giving defense contractors that handle Controlled Unclassified...

/NOT FOR DISSEMINATION, RELEASE OR PUBLICATION IN OR INTO THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES/TSXV: PGZ   |   OTCQB: PGZFF   |   FRA: 2EU...